Bellerophon (BLPH)

Bellerophon (BLPH) Stock Price & Analysis


BLPH Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.67 - $12.58
Previous Close$6.89
Average Volume (3M)1.26M
Market Cap
Enterprise Value$56.40M
Total Cash (Recent Filing)$15.61M
Total Debt (Recent Filing)$8.00K
Price to Earnings (P/E)-5.7
Aug 03, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.22
Shares Outstanding10,449,834
10 Day Avg. Volume162,664
30 Day Avg. Volume1,255,300
Standard Deviation0.50
Financial Highlights & Ratios
Price to Book (P/B)12.89
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)5.50
P/FCF Ratio5.50
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-3.72
Price Target Upside371.70% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Bellerophon’s price range in the past 12 months?
Bellerophon lowest stock price was $0.67 and its highest was $12.58 in the past 12 months.
    What is Bellerophon’s market cap?
    Currently, no data Available
    When is Bellerophon’s upcoming earnings report date?
    Bellerophon’s upcoming earnings report date is Aug 03, 2023 which is in 62 days.
      How were Bellerophon’s earnings last quarter?
      Currently, no data Available
      Is Bellerophon overvalued?
      According to Wall Street analysts Bellerophon’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
        Does Bellerophon pay dividends?
        Bellerophon does not currently pay dividends.
        What is Bellerophon’s EPS estimate?
        Bellerophon’s EPS estimate is -$0.46.
          How many shares outstanding does Bellerophon have?
          Bellerophon has 10,449,834 shares outstanding.
            What happened to Bellerophon’s price movement after its last earnings report?
            Currently, no data Available
            Which hedge fund is a major shareholder of Bellerophon?
            Among the largest hedge funds holding Bellerophon’s share is Perceptive Advisors LLC. It holds Bellerophon’s shares valued at 7M.


              Bellerophon Stock Smart Score

              The Bellerophon stock analysis is based on the TipRanks Smart Score which is derived from 8 unique data sets including Analyst recommendations, Crowd Wisdom, Hedge Fund Activity, Media Sentiment and multiple Technical stock factors. The Smart Score is a quantitative, data-driven rating system and does not include human intervention.
              Learn more about TipRanks Smart Score

              Company Description


              Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company, which focuses on developing innovative products at the intersection of drugs and devices that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The company engages in two programs including INOpulse and BCM. INOpulse is based on proprietary pulsatile nitric oxide delivery device. BCM is based on placebo-controlled clinical trial designed to support CE mark registration in the European Union. Bellerophon Therapeutics was founded in 2009 and is headquartered in Warren, NJ.


              Top 5 ETFs holding BLPH

              Currently, no data available
              Please return soon. This page is being updated.
              Up to five ETFs with an Outperform Smart Score that hold BLPH. The ETFs are listed according to market value of BLPH within the ETF


              Forecast EPS vs Actual EPS

              Currently, no data available
              Please return soon. This page is being updated.

              Similar Stocks
              Price & Change
              Aptose Biosciences
              Calithera Bio
              Cyclacel Pharmaceuticals
              G1 Therapeutics

              Popular Stocks

              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis